Galip Güz

1.2k total citations
74 papers, 858 citations indexed

About

Galip Güz is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Galip Güz has authored 74 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 18 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Galip Güz's work include Dialysis and Renal Disease Management (12 papers), Renal Diseases and Glomerulopathies (9 papers) and Iron Metabolism and Disorders (6 papers). Galip Güz is often cited by papers focused on Dialysis and Renal Disease Management (12 papers), Renal Diseases and Glomerulopathies (9 papers) and Iron Metabolism and Disorders (6 papers). Galip Güz collaborates with scholars based in Türkiye, United States and United Kingdom. Galip Güz's co-authors include Siren Sezer, Fatma Nurhan Özdemir, Z. Arat, Mehmet Kanbay, Şükrü Sindel, Musa Bali, Mehmet Haberal, Yasemin Erten, Şengül Özdek and Umut Aslı Dinç and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Kidney Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Galip Güz

71 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galip Güz Türkiye 17 197 188 149 147 125 74 858
Nüket Bavbek Türkiye 21 489 2.5× 130 0.7× 242 1.6× 222 1.5× 123 1.0× 56 1.3k
Amy Wang United States 15 288 1.5× 268 1.4× 255 1.7× 92 0.6× 80 0.6× 35 1.2k
Carsten A. Böger Germany 20 369 1.9× 190 1.0× 273 1.8× 163 1.1× 44 0.4× 58 1.2k
Xiaojiang Zhan China 15 232 1.2× 111 0.6× 140 0.9× 123 0.8× 116 0.9× 65 844
Ricardo Lauzurica Spain 18 196 1.0× 138 0.7× 254 1.7× 315 2.1× 56 0.4× 87 1.1k
Anja Mühlfeld Germany 15 213 1.1× 147 0.8× 200 1.3× 195 1.3× 66 0.5× 27 912
Antoine Buemi Italy 17 568 2.9× 184 1.0× 258 1.7× 123 0.8× 108 0.9× 57 1.2k
Kriengsak Vareesangthip Thailand 15 239 1.2× 92 0.5× 75 0.5× 155 1.1× 76 0.6× 42 740
Beatriz Bayés Spain 17 328 1.7× 80 0.4× 252 1.7× 198 1.3× 61 0.5× 44 962
Kiran Parmar United Kingdom 18 82 0.4× 97 0.5× 103 0.7× 99 0.7× 305 2.4× 40 1.4k

Countries citing papers authored by Galip Güz

Since Specialization
Citations

This map shows the geographic impact of Galip Güz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galip Güz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galip Güz more than expected).

Fields of papers citing papers by Galip Güz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galip Güz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galip Güz. The network helps show where Galip Güz may publish in the future.

Co-authorship network of co-authors of Galip Güz

This figure shows the co-authorship network connecting the top 25 collaborators of Galip Güz. A scholar is included among the top collaborators of Galip Güz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galip Güz. Galip Güz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helvacı, Özant, Hasan Selçuk Özger, Pınar Aysert Yıldız, et al.. (2024). Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients. Journal of Medical Virology. 96(11). e70030–e70030.
2.
Oğuz, Ebru Gök, et al.. (2020). The reliability and success of peritoneal dialysis during the COVID‐19 pandemic. Seminars in Dialysis. 34(2). 147–156. 24 indexed citations
3.
Tükün, Ajlan, et al.. (2020). Vitamin D receptor polymorphisms and bone health after kidney transplantation. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(2). 802–812. 5 indexed citations
4.
Helvacı, Özant, et al.. (2020). Kidney biopsy in the elderly: diagnostic adequacy and yield. International Urology and Nephrology. 53(1). 105–109. 1 indexed citations
5.
İnal, Salih, et al.. (2014). Fibromyalgia and Nondipper Circadian Blood Pressure Variability. JCR Journal of Clinical Rheumatology. 20(8). 422–426. 12 indexed citations
6.
Ünverdi, Selman, Salih İnal, Hatǐce Ünverdǐ, et al.. (2013). Is colchicine therapy effective in all patients with secondary amyloidosis?. Renal Failure. 35(8). 1071–1074. 12 indexed citations
7.
Turan, Nedim, Mustafa Beneklı, Salih İnal, et al.. (2012). Sunitinib- and Sorafenib-lnduced Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor. Annals of Pharmacotherapy. 46(10). 1438–1438. 14 indexed citations
8.
Uz, Ebru, Hacer Haltaş, Nüket Bavbek, et al.. (2011). Karyomegalic tubulointerstitial nephritis: A rare cause of chronic kidney disease. Nephro-Urology Monthly. 2011(3). 201–203. 5 indexed citations
9.
Değer, Serpil Müge, et al.. (2011). A Case of an Accelerated Uremic Neuropathy. Renal Failure. 33(3). 371–372. 6 indexed citations
10.
Dinç, Umut Aslı, Şengül Özdek, Zeynep Aktaş, Galip Güz, & Merih Önol. (2010). Changes in intraocular pressure, and corneal and retinal nerve fiber layer thickness during hemodialysis. International Ophthalmology. 30(4). 337–340. 41 indexed citations
11.
Yeğin, Zeynep Arzu, Serpil Müge Değer, Hatîce Paşaoğlu, et al.. (2008). The Relationship between the MEFV Genotype, Clinical Features, and Cytokine-Inflammatory Activities in Patients with Familial Mediterranean Fever. Renal Failure. 30(2). 187–191. 19 indexed citations
12.
Demirağ, Mehmet Derya, Hacer İlke Önen, Meral Yirmibeş Karaoğuz, et al.. (2007). Apolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 52(12). 3399–3403. 28 indexed citations
13.
Güz, Galip, Billur Demiroğulları, Nuriye Nuray Ulusu, et al.. (2007). STOBADINE PROTECTS RAT KIDNEY AGAINST ISCHAEMIA/REPERFUSION INJURY. Clinical and Experimental Pharmacology and Physiology. 34(3). 210–216. 23 indexed citations
14.
Özdek, Şengül, et al.. (2007). Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure. Nephrology. 12(4). 380–385. 40 indexed citations
15.
Güz, Galip, Asife Şahinarslan, Annemieke Dhondt, et al.. (2004). Elevated Cardiac Troponin T in Hemodialysis Patients Receiving More Intravenous Iron Sucrose. Renal Failure. 26(6). 663–672. 6 indexed citations
16.
Özdemir, Fatma Nurhan, Galip Güz, Siren Sezer, et al.. (2001). Atherosclerosis Risk Is Higher in Continuous Ambulatory Peritoneal Dialysis Patients Than in Hemodialysis Patients. Artificial Organs. 25(6). 448–452. 15 indexed citations
17.
Sezer, Siren, Fatma Nurhan Özdemir, Galip Güz, et al.. (2001). Ferritin levels can be a good predictor for HCV viremia in potential renal transplant candidates. Transplantation Proceedings. 33(5). 2796–2798. 7 indexed citations
18.
Güz, Galip, B. Handan Özdemir, Siren Sezer, et al.. (2000). High Frequency of Amyloid Lymphadenopathy in Uremic Patients. Renal Failure. 22(5). 613–621. 1 indexed citations
19.
Güz, Galip, et al.. (2000). Two renal transplants from one cadaveric donor: one recipient with simultaneous B cell lymphoma and Kaposi's sarcoma, and the other with T cell lymphoma. Nephrology Dialysis Transplantation. 15(8). 1242–1244. 5 indexed citations
20.
Özdemir, Nurhan, et al.. (1999). Anticardiolipin antibodies in hemodialysis patients. Transplantation Proceedings. 31(8). 3388–3389. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nüket Bavbek Breakdown of academic impact, for papers by Amy Wang Breakdown of academic impact, for papers by Carsten A. Böger Breakdown of academic impact, for papers by Xiaojiang Zhan Breakdown of academic impact, for papers by Ricardo Lauzurica Breakdown of academic impact, for papers by Anja Mühlfeld Breakdown of academic impact, for papers by Antoine Buemi Breakdown of academic impact, for papers by Kriengsak Vareesangthip Breakdown of academic impact, for papers by Beatriz Bayés Breakdown of academic impact, for papers by Kiran Parmar
Rankless by CCL
2026